Support for people with Alzheimer and their caregiver by the Alzheimer’s association

Alzheimer; News from the web:

From The Alzheimer’s Association:

The Alzheimer’s Association provides supportive programs and services to help people with Alzheimer’s and their caregivers deal with the disease and its impact on their lives. In the early stage of Alzheimer’s disease, families face brand new questions as they adjust. Alzheimer’s Association support groups not only provide answers, but offer a forum for individuals to talk about their experiences.

The Alzheimer’s Association, Central New York Chapter welcomes individuals in the early stages of Alzheimer’s disease or a related dementia and their caregivers to a monthly support group tailored to their needs. The group meets monthly on the fourth Friday at 10 a.m. at the Chapter’s Southern Tier office, 401 Hayes Ave., Endicott.

“The purpose of early-stage support groups is to provide a safe and supportive environment of peers who are living in the early stages of Alzheimer’s disease or a related dementia and their care partners,” said Catherine James, the Chapter’s chief executive officer.

Individuals seeking to take part in the group must be interviewed in advance by Alzheimer’s Association staff to determine whether they are appropriate to participate. Call (607) 785-7852 x119 to inquire.

visit us at AlzheimerHeadlines.com

Eli Lilly brings hope for Alzheimer

Alzheimer; News from the web:

Eli Lilly comes out with a very confident statement that it will “write medical history” this time for the sufferers of Alzheimer.

Well call me skeptical  because we have heard this so many times before but every-time a company spokesman come out with stories like this, we continue to report it and wait to see the results. See in our link the write up by Huffington Post with some of the analysts views on this latest breaking news.

Read all about it HERE

visit us at AlzheimerHeadlines.com

New approach for Alzheimer research

Alzheimer; News from the web:

A new study from the University of Dalhousie in Halifax. They have found a novel way to go about attacking the disease. In their own words:

There may exist endogenous compounds within the brain that play a role in inhibiting aggregation. We have devised a unique in silico screening strategy of endogenous molecules within the human brain, with special emphasis on amino acid metabolic pathways, to identify compounds with the potential to inhibit Aβ aggregation. Metabolites of tryptophan were computationally identified through this screening as potential therapeutics and were optimized via molecular modelling to determine their capacity to bind to Aβ. The most successful molecule identified was 3-hydroxyanthranilic acid (3-HAA). This endogenous molecule was then computationally explored to design novel analogues of 3-HAA with the goal of improving Aβ antiaggregant activity. These combined in silico methods of screening, identifying, and successfully “analoguing” an endogenous molecule of the brain as an AD therapeutic has yielded positive results and a novel approach to computer-aided drug design.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Is LMTX the cure for Alzheimer

Alzheimer; News from the web:

We continue to be skeptical of claims that there would be a wonderpil to cure Alzheimer.

Well the Times of India, cites the Daily Mail to have found British scientist who have done just that and invented a wonderpil that will be on the market in a few years. We love to believe it, but have been disappointed before.

Read all about it HERE

visit us at AlzheimerHeadlines.com